Achieving optimal glycemic outcomes is critical for effective management of diabetes, and basal-bolus treatment regimens are currently seen as the standard of care for insulin injection therapy for fasting and post-prandial glucose in people with diabetes (PwD) [1–3]. Here, INS is linked to diabetes mellitus.